https://kempharm-1.reportablenews.com daily 1.0 https://kempharm-1.reportablenews.com/pr/kempharm-reports-third-quarter-financial-results-and-provides-corporate-update 2022-12-20T14:18:50Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/kempharm-an-astute-acquisition-with-new-opportunities 2022-09-07T10:56:15Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/kempharm-reports-first-quarter-2022-financial-results-and-corporate-update 2022-05-19T10:06:41Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/fourth-quarter-and-fiscal-year-2021-financial-results-and-corporate-updates 2022-04-13T10:33:02Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/organic-pipeline-expansion-cns-rare-disease-focus-of-multiple-products-to-drive-growth 2022-02-28T15:08:47Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/kempharm-q3-earnings-call 2022-01-10T13:16:37Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/solid-fundamentals-kempharm-is-now-focused-on-the-next-wave-for-growth 2021-12-09T09:15:00Z monthly 0.5 https://kempharm-1.reportablenews.com/pr/twice-validated-and-now-building-from-a-position-of-strength 2021-10-13T10:14:32Z monthly 0.5